Law360 (May 8, 2020, 6:12 PM EDT) -- Novartis Pharmaceuticals Corp., Bausch Health US LLC and other pharmaceutical companies got a win in a suit alleging two generic drugs caused a user's Peyronie's disease, with a Texas federal judge finding that the bulk of the claims are preempted by federal and state law.
U.S. District Judge Orlando L. Garcia on Thursday dismissed with prejudice claims by Ramon D. Johnson II against Novartis, Bausch, Taro Pharmaceuticals USA Inc., Sun Pharmaceutical Industries Ltd. and Torrent Pharma Inc.
In the suit, Johnson alleged that two generic drugs he took for an unrelated condition — minocycline and carbamazepine — caused his Peyronie's disease,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!